Back to School: How biopharma can reboot drug development. Access exclusive analysis here

APC8024: Phase I

In an ongoing Phase I study in 16 patients, 1 patient

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE